| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Genetics Branch,* Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Vysis, Incorporated/Abbott Laboratories, Downers Grove, Illinois; Cancer Genetics, Incorporated, Milford, Massachusetts; Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden; and Klinik Kloster Paradiese,¶ Laboratory of Cytopathology, Soest, Germany
Invasive cervical carcinomas almost invariably carry extra copies of chromosome arm 3q, resulting in a gain of the human telomerase gene (TERC). This provided the rationale for the development of a multicolor fluorescence in situ hybridization (FISH) probe set as a diagnostic tool for the direct detection of TERC gains in Pap smears. We previously used this probe set to show that cervical intraepithelial neoplasia (CIN) 2 and CIN3 lesions could be distinguished from normal samples, atypical squamous cell of undetermined significance (ASCUS) and CIN1, with a sensitivity and specificity exceeding 90%, independent of the cytomorphological assessment. In the current study, we explored whether gain of 3q and amplification of TERC could predict progression from CIN1/CIN2 to CIN3 and invasive carcinoma. We applied our probe set to a series of 59 previously stained Pap smears for which repeat Pap smears and clinical follow-up were available. The samples included CIN1/CIN2 lesions that progressed to CIN3 (progressors), CIN1/CIN2 lesions that regressed spontaneously (regressors), and normal Pap smears from women who subsequently developed CIN3 or cervical cancer. Here, we show that progressors displayed a gain of 3q whereas none of the regressors showed this genetic aberration. These data suggest that 3q gain is required for the transition from CIN1/CIN2 to CIN3 and that it predicts progression. Of note, 3q gain was found in 33% of cytologically normal Pap smears from women who were diagnosed with CIN3 or invasive cervical carcinoma after a short latency. The sensitivity of our test for predicting progression from CIN1/CIN2 to CIN3 was 100% and the specificity, ie, the prediction of regression, was 70%. We conclude that the detection of 3q gain and amplification of TERC in routinely collected Pap smears can assist in identifying low-grade lesions with a high progression risk and in decreasing false-negative cytological screenings.
This article has been cited by other articles:
 |
|
 |
|
  J. P. Klussmann, J. J. Mooren, M. Lehnen, S. M.H. Claessen, M. Stenner, C. U. Huebbers, S. J. Weissenborn, I. Wedemeyer, S. F. Preuss, J. M.J.A.A. Straetmans, et al. Genetic Signatures of HPV-related and Unrelated Oropharyngeal Carcinoma and Their Prognostic Implications Clin. Cancer Res., March 1, 2009; 15(5): 1779 - 1786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Wilting, R. D.M. Steenbergen, M. Tijssen, W. N. van Wieringen, T. J.M. Helmerhorst, F. J. van Kemenade, M. C.G. Bleeker, M. A. van de Wiel, B. Carvalho, G. A. Meijer, et al. Chromosomal Signatures of a Subset of High-Grade Premalignant Cervical Lesions Closely Resemble Invasive Carcinomas Cancer Res., January 15, 2009; 69(2): 647 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Steinau, M. S. Rajeevan, D. R. Lee, M. T. Ruffin, I. R. Horowitz, L. C. Flowers, T. Tadros, G. Birdsong, M. Husain, D. C. Kmak, et al. Evaluation of RNA Markers for Early Detection of Cervical Neoplasia in Exfoliated Cervical Cells Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 295 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Jung, R. Kindich, J. Kamradt, M. Jung, M. Muller, W. A. Schulz, R. Engers, G. Unteregger, M. Stockle, R. Zimmermann, et al. Genomic and Expression Analysis of the 3q25-q26 Amplification Unit Reveals TLOC1/SEC62 as a Probable Target Gene in Prostate Cancer Mol. Cancer Res., March 1, 2006; 4(3): 169 - 176. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
